About Us

What We Do

Transform Science into Actionable Solutions 

Empower Physicians and Patients with Evidence-based Information to Fight Cancer 

We are the world's leading cancer solution provider. Based in Taiwan, we also provide effective services through our offices in Singapore, Hong Kong and Japan. Joint by experts from the field of cancer biology, cancer genomics and bioinformatics, we provide optimal cancer treatment plan, cancer relapse and drug resistance monitoring as well as cancer risk assessment and immunotherapy evaluation. We are dedicated to provide every cancer patient personalized genomic information based-treatment plans through our cutting-edge Next Generation Sequencing (NGS) platform, medical report and integrated services.


What We Have

Asian Genome Data Base

We integrate genomic databases information with Asia specific genome profiling

Cutting-edge NGS Service Platform

We provide precise cancer genetic variants detection through minimum tumor samples through our ultra-sensitive NGS Platform.

Highest standard Lab with international accreditation

We are recognized and certified by the highest international standard CAP (NGS) accreditation, SNQ and more.

Professional Bioinformatics and Biomedical Team

We are strengthened by dozens of bioinformatics and biomedical professionals.

Integrated Comprehensive Cancer Services

We engage from every angle, preliminary research collaboration, international biopharma drug development, clinicians consultation and patient education.

The most valuable medical report and services

We deliver medical reports with genetic variants information, therapeutic implications and also provide comprehensive consultation services to empower physicians with evidence based-precise information.


Our Vision

To rewrite the existing model of cancer diagnostic, cancer treatment and cancer monitoring. Make Cancer Manageable.


Our Core Value

Technology for Humanity
Your Health, We Care

Cancer is the second leading cause of death and estimated with 70% increase of newly diagnosed cases. Asia’s cancer death rate is higher than developed countries for delayed diagnosis and lack of treatment options (WHO 2017.2). Many of our people here at ACT Genomics are driven to make a difference in this battle with cancer by the experience of facing cancer at close range. Every one of us are devoted to this fight against cancer.

 

Our Belief

ACT Genomics can make cancer manageable and provide cancer patients to live a better life with dignity and quality

We truly believe that ACT Genomics can change the existing cancer treatment model and make cancer manageable. To enable patients and their family to walk through this journey of fighting cancer with dignity, precise comprehensive cancer management facilitates treatment with higher efficiency and accuracy


 

Management Team

Hua Chien Chen, Ph.D
Chief Executive Officer

Shu Jen Chen, Ph.D
Chief Scientific Officer

Joe Hsueh, MBA
Chief Operating Officer

Victor Chan, CFA, LLB, MBA
Acting Chief Financial Officer

Allen Lai, M.D Ph.D
Regional Managing Director

Eddie Liu, MBA
Managing Director, Hong Kong

 

 

Milestone

Careers

ACT Genomics is an international leader in precision medicine, and we provide a broad range of career opportunities. In Taiwan, we are the only company able to transform cancer genomic information into precision diagnosis and personalized treatments.

 

More recruit information please go to 104 webpage : http://www.104.com.tw

 

Help. Inspire. Take Action

As a molecular information provider, we highly value our people. We know that the key to success is to use our passion to make a difference in the world. Therefore, we encourage our people to take initiative at every single step, to benefit our cancer patients and to improve ourselves every day. We help each other to grow and inspire each other for more innovative ideas. Together as a family, we are fearless. Dream big and take action, we never fight alone!